Nowadays, lung cancer is one of the most lethal diseases, being responsible of over 28% of all worldwide cancer-related deaths. It is well known that the effectiveness of lung cancer treatments is directly related with its early detection and diagnosis. European Union financing has allowed eight prestigious research groups to cooperate together in a European Project  (A nanoscale artificial nose to easily detect volatile biomarkers at early stages of lung cancer and related genetic mutations, LCAOS)

Its main goal is the design and assemblage of a device capable of detecting lung cancer in its early stages through non-invasive procedures based on exhaled breath analyses.

Each one of the research groups that participate in the project has been assigned with a specific task in order to reach the final device. The Spanish group (LCAOS España) is in charge of the design and optimization of algorithms for the creation of models using the data obtained from the breath analyses.

LCAOS is a European Project that began on 1st April 2011 that has as main goals the development of non-invasive methods for the early diagnosis of lung cancer and allowing the potential possibility of predicting its appearance in a given person. These methods are based on detecting lung cancer-related biomarkers present in the people’s exhaled breath.

The Spanish group will lead the development of the most suitable mathematical algorithms that will treat the data from the breath analyses in order to establish the fastest and most accurate diagnosis possible.





The LCAOS consortium is formed by eight partners from five different European countries and one associated country: Austria, Germany, Israel, the Netherlands, Spain, and United Kingdom.


  1. Technion – Israel Institute of Technology (Coordinator); Haifa - Israel
    Leader: Prof. Hossam Haick
  2. Max-Planck Institute for the Science of Light; Erlangen - Germany
    Leader: Dr. Silke Christiansen
  3. University of Liverpool; Liverpool - United Kingdom
    Leader: Prof. John K. Field
  4. Tel Aviv University; Tel Aviv - Israel
    Leader: Dr. Nir Peled
  5. Complutense University of Madrid; Madrid - Spain
    Leader: Dr. Jose S. Torrecilla
  6. Micronit Microfluidics BV; Enschede- The Nehterlands
    Leader: Dr. Eng. Marko Blom

  7. JLM Innovation GmbH; Tübingen - Germany
    Leader: Dr. Jan Mitrovics
  8. IONIMED Analytik GmbH; Innsbruck - Austria
    Leader: Dr. Jens Herbig